PMC9334881_01
Brain MRI of the patient. The imaging was obtained at T
6 and shows global alterations suggesting a primary neurodegenerative condition. Relative preservation of medial temporal lobe volume can be observed.
j_tnsci-2022-0230-fig001.jpg
PMC9334881_01_j_tnsci-2022-0230-fig001.jpg
j_tnsci-2022-0230_fig_001
Simultaneously, the brain MRI (Figure 1) documented frontal atrophy and an altered signal in occipital areas, thus supporting the initial hypothesis of a neuro-organic disease underpinning the ES.
DaT Scan of the patient. The imaging was obtained between T
7 and T
8.
j_tnsci-2022-0230-fig002.jpg
PMC9334881_01_j_tnsci-2022-0230-fig002.jpg
j_tnsci-2022-0230_fig_002
Furthermore, following the neurologist's consultation, a DaT Scan was requested in order to exclude Parkinson's disease, which found no substantial alteration of the nigrostriatal dopaminergic system, confirming that the extrapyramidal symptoms was exclusively due to an iatrogenic parkinsonism from the administration of PP-LAI injections (Figure 2).